Raymond James & Associates Citius Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.51 - $2.2 $17,470 - $25,454	-11,570 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$1.74 - $2.6 $121 - $182	70 Added 0.61%	11,570 $23,000
Q2 2021 Aug 11, 2021	BUY	$1.51 - $4.23 $17,365 - $48,645	11,500 New	11,500 $40,000
Q2 2020 Jul 28, 2020	SELL	$0.65 - $1.45 $7,800 - $17,400	-12,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.65 - $5.1 $31,800 - $61,199	12,000	12,000 $46,000

26.7M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $140M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.